chr17-4632019-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001140.5(ALOX15):c.1679C>T(p.Thr560Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.02 in 1,613,394 control chromosomes in the GnomAD database, including 659 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.017 ( 47 hom., cov: 33)
Exomes 𝑓: 0.020 ( 612 hom. )
Consequence
ALOX15
NM_001140.5 missense
NM_001140.5 missense
Scores
5
8
5
Clinical Significance
Conservation
PhyloP100: 3.21
Genes affected
ALOX15 (HGNC:433): (arachidonate 15-lipoxygenase) This gene encodes a member of the lipoxygenase family of proteins. The encoded enzyme acts on various polyunsaturated fatty acid substrates to generate various bioactive lipid mediators such as eicosanoids, hepoxilins, lipoxins, and other molecules. The encoded enzyme and its reaction products have been shown to regulate inflammation and immunity. Multiple pseudogenes of this gene have been identified in the human genome. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0038241744).
BP6
Variant 17-4632019-G-A is Benign according to our data. Variant chr17-4632019-G-A is described in ClinVar as [Benign]. Clinvar id is 624559.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.061 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALOX15 | NM_001140.5 | c.1679C>T | p.Thr560Met | missense_variant | 13/14 | ENST00000293761.8 | NP_001131.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALOX15 | ENST00000293761.8 | c.1679C>T | p.Thr560Met | missense_variant | 13/14 | 1 | NM_001140.5 | ENSP00000293761 | P1 | |
ALOX15 | ENST00000570836.6 | c.1679C>T | p.Thr560Met | missense_variant | 14/15 | 2 | ENSP00000458832 | P1 | ||
ALOX15 | ENST00000574640.1 | c.1562C>T | p.Thr521Met | missense_variant | 13/14 | 2 | ENSP00000460483 |
Frequencies
GnomAD3 genomes AF: 0.0169 AC: 2578AN: 152174Hom.: 47 Cov.: 33
GnomAD3 genomes
AF:
AC:
2578
AN:
152174
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0274 AC: 6861AN: 250268Hom.: 339 AF XY: 0.0235 AC XY: 3181AN XY: 135222
GnomAD3 exomes
AF:
AC:
6861
AN:
250268
Hom.:
AF XY:
AC XY:
3181
AN XY:
135222
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0203 AC: 29658AN: 1461102Hom.: 612 Cov.: 33 AF XY: 0.0194 AC XY: 14092AN XY: 726768
GnomAD4 exome
AF:
AC:
29658
AN:
1461102
Hom.:
Cov.:
33
AF XY:
AC XY:
14092
AN XY:
726768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0169 AC: 2579AN: 152292Hom.: 47 Cov.: 33 AF XY: 0.0167 AC XY: 1242AN XY: 74462
GnomAD4 genome
AF:
AC:
2579
AN:
152292
Hom.:
Cov.:
33
AF XY:
AC XY:
1242
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
68
ALSPAC
AF:
AC:
62
ESP6500AA
AF:
AC:
17
ESP6500EA
AF:
AC:
144
ExAC
AF:
AC:
2785
Asia WGS
AF:
AC:
30
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Asthma, nasal polyps, and aspirin intolerance Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Mar 26, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
D;D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
M;M;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Pathogenic
.;D;.
REVEL
Uncertain
Sift
Pathogenic
.;D;.
Sift4G
Pathogenic
D;D;D
Polyphen
D;D;.
Vest4
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at